Identification and Validation of circDOCK1/miR-138-5p/GRB7 Axis for Promoting Breast Cancer Progression
Introduction Human epidermal growth factor receptor 2 (HER2) positive breast cancer accounts for 20–25% of all the breast cancer patients.1 With the development of targeted treatment strategies, the outcome of patients with HER-2 positive breast cancer has …